Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Characterization of Circulating Tumor Cells Before and After Treatment in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma

NCT06448611 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06448611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06448611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Characterization of Circulating Tumor Cells Before and After Treatment in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2024
Completion date
June 1, 2027
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

merkel cell carcinoma